EGRX logo

Eagle Pharmaceuticals (EGRX) Total Assets

Annual Total Assets

$406.16 M
+$152.43 M+60.07%

December 31, 2022


Summary


Performance

EGRX Total Assets Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherEGRXbalance sheetmetrics:

Quarterly Total Assets

$404.82 M
-$9.35 M-2.26%

June 30, 2023


Summary


Performance

EGRX Quarterly Total Assets Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherEGRXbalance sheetmetrics:

Total Assets Formula

Total Assets = Current Assets + Non-Current Assets

EGRX Total Assets Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+60.1%+6.0%
3 y3 years+59.6%+57.7%
5 y5 years+50.4%+47.8%

EGRX Total Assets Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+60.1%-2.3%+59.5%
5 y5-yearat high+60.4%-2.3%+63.1%
alltimeall timeat high+4203.4%-2.3%+2147.8%

Eagle Pharmaceuticals Total Assets History

DateAnnualQuarterly
Jun 2023
-
$404.82 M(-2.3%)
Mar 2023
-
$414.18 M(+2.0%)
Dec 2022
$406.16 M(+60.1%)
$406.16 M(+5.1%)
Sep 2022
-
$386.45 M(+1.2%)
Jun 2022
-
$381.76 M(+19.2%)
Mar 2022
-
$320.17 M(+26.2%)
Dec 2021
$253.73 M(+0.2%)
$253.73 M(-1.0%)
Sep 2021
-
$256.26 M(-3.0%)
Jun 2021
-
$264.24 M(+1.6%)
Mar 2021
-
$259.97 M(+2.7%)
Dec 2020
$253.19 M(-0.5%)
$253.19 M(+2.0%)
Sep 2020
-
$248.16 M(-3.3%)
Jun 2020
-
$256.71 M(-29.1%)
Mar 2020
-
$361.94 M(+42.2%)
Dec 2019
$254.55 M(+6.7%)
$254.55 M(-1.0%)
Sep 2019
-
$257.04 M(-1.8%)
Jun 2019
-
$261.63 M(+0.8%)
Mar 2019
-
$259.45 M(+8.7%)
Dec 2018
$238.60 M
$238.60 M(-11.2%)
Sep 2018
-
$268.79 M(-1.9%)
DateAnnualQuarterly
Jun 2018
-
$273.94 M(+9.9%)
Mar 2018
-
$249.30 M(-7.7%)
Dec 2017
$270.06 M(+26.0%)
$270.06 M(+1.2%)
Sep 2017
-
$266.89 M(+21.2%)
Jun 2017
-
$220.18 M(-2.1%)
Mar 2017
-
$224.82 M(+4.9%)
Dec 2016
$214.32 M(+72.0%)
$214.32 M(+46.1%)
Sep 2016
-
$146.72 M(-1.8%)
Jun 2016
-
$149.37 M(+16.1%)
Mar 2016
-
$128.70 M(+3.3%)
Dec 2015
$124.61 M(+133.3%)
$124.61 M(+2.0%)
Sep 2015
-
$122.22 M(+1.0%)
Jun 2015
-
$121.03 M(-6.9%)
Mar 2015
-
$129.93 M(+159.4%)
Dec 2014
-
$50.09 M(-6.2%)
Sep 2014
$53.41 M(+195.0%)
$53.41 M(-8.2%)
Jun 2014
-
$58.16 M(-9.1%)
Mar 2014
-
$63.96 M(+255.1%)
Dec 2013
-
$18.01 M(-0.5%)
Sep 2013
$18.10 M(+91.8%)
$18.10 M
Sep 2012
$9.44 M
-

FAQ

  • What is Eagle Pharmaceuticals annual total assets?
  • What is the all time high annual total assets for Eagle Pharmaceuticals?
  • What is Eagle Pharmaceuticals annual total assets year-on-year change?
  • What is Eagle Pharmaceuticals quarterly total assets?
  • What is the all time high quarterly total assets for Eagle Pharmaceuticals?
  • What is Eagle Pharmaceuticals quarterly total assets year-on-year change?

What is Eagle Pharmaceuticals annual total assets?

The current annual total assets of EGRX is $406.16 M

What is the all time high annual total assets for Eagle Pharmaceuticals?

Eagle Pharmaceuticals all-time high annual total assets is $406.16 M

What is Eagle Pharmaceuticals annual total assets year-on-year change?

Over the past year, EGRX annual total assets has changed by +$152.43 M (+60.07%)

What is Eagle Pharmaceuticals quarterly total assets?

The current quarterly total assets of EGRX is $404.82 M

What is the all time high quarterly total assets for Eagle Pharmaceuticals?

Eagle Pharmaceuticals all-time high quarterly total assets is $414.18 M

What is Eagle Pharmaceuticals quarterly total assets year-on-year change?

Over the past year, EGRX quarterly total assets has changed by +$23.07 M (+6.04%)